cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle
about
Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialDiscovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agentRevisiting the Logan plot to account for non-negligible blood volume in brain tissue.Endothelial dysfunction and vascular disease - a 30th anniversary update.Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo.
P2860
cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle
description
scientific article published on 07 June 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
name
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@en
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@nl
type
label
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@en
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@nl
prefLabel
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@en
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@nl
P2860
P1476
cGMP phosphodiesterase inhibit ...... of insulin in skeletal muscle
@en
P2093
E A Bradley
S Rattigan
P2860
P304
P356
10.1152/AJPENDO.00691.2010
P577
2011-06-07T00:00:00Z